Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 24, 2008

Clinical Data and Affymetrix Sign  Marketing Deal for New Drug Metabolism Service

  • Clinical Data and Affymetrix signed a marketing agreement for Affymetrix’ drug metabolizing enzymes and transporter (DMET) early access solution. Cogenics and Epidauros Biotechnologie, both subsidiaries of Clinical Data, will offer the DMET services on a global basis, with limited exclusivity in Europe.

    The DMET early access solution provides a method for assaying the genetics of drug metabolism, according to Affymetrix.



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »